Growth hormone releasing peptide

We are Growth hormone releasing peptide CAS:87616-84-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Growth hormone releasing peptide
CAS.NO:87616-84-0
Synonyms:Growth hormone releasing peptide
GHRP-6 Acetate
GH-Releasing hexapeptide 6
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 1407.0±65.0 °C at 760 mmHg
Molecular Formula C46H56N12O6
Molecular Weight 873.014
Flash Point 804.7±34.3 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.664
 
Specification:
Appearance:White to off-white powder
Assay:≥95.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:1.Lowers body fat: GHRP-6 administration has the reputation of lowering fat, making it a good option for bodybuilders in their cutting cycles. It is also extremely attractive to those people who are weight conscious and are looking to shed those extra pounds without working hard at the gym.
2.Increase muscle: GHRP-6 administration also has the reputation of facilitating an increase and development in muscles.
3.Increase stamina: Those users who are vouching for the drug claim improvement in stamina levels post the administration of GHRP-6.
4.Is protective and anti-inflammatory: GHRP-6 administration initiates better protection of the muscles and acts as an anti-inflammatory agent which is crucial in the muscle recovery process and synthesis. 

Growth hormone releasing peptide


Related News: Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.385425-15-0 “So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.6,7-Dimethoxyquinazoline-2,4-dione CAS:28888-44-0 Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.4-Fluoro-3-nitrotoluene ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.

Related Products
Product Name
Methyl 6-bromopicolinate View Details
DMDM Hydantoin Cas:6440-58-0 View Details
Diisopropyl malonate View Details
2-Cyanophenylboronic acid manufacturer tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate manufacturer 1-(3-Amino-2-hydroxyphenyl)ethanone manufacturer ((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate manufacturer N-Cbz-glycine Ethyl Ester manufacturer